Adult Spinal Muscular Atrophy (SMA) China Registry
About the study
The primary objective of the study is to describe the natural history and utilization of disease modifying therapy (DMT) among adult Chinese participants with SMA linked to chromosome 5q (5q-SMA).
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Key Inclusion Criteria:
-Genetically confirmed 5q-SMA.
EXCLUSION CRITERIA
Key Exclusion Criteria:
-Other types of SMA (non 5q-SMA).
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Muscular Atrophy, Spinal
Age (in years)
18+
Participants needed
200
Est. Completion Date
Jun 1, 2028
Treatment type
OBSERVATIONAL
Sponsor
Biogen
ClinicalTrials.gov identifier
NCT05618379
Study number
CN-SMG-11772
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?